Published date: 25 October 2019
Last edited date: 3 June 2020
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
Any region, Scotland, Wales, Northern Ireland
Value of contract
£0
Procurement reference
CM/EMP/15/5473/662
Published date
25 October 2019
Approach to market date
8 June 2020
Contract start date
1 April 2021
Contract end date
31 March 2022
Procedure type
Restricted procedure (above threshold)
A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Please be aware that initial indications to the market was that this opportunity would be for a framework agreement. This has now changed to a requirement for a contract to be put in place.
The purpose of the procurement exercise will be intended to establish a contract for Public Health England's requirements for the stockpile of emergency medicines. This includes the provision of: atropine PFS, ciprofloxacin tablets (including 100 mg strength) ciprofloxacin suspension and ciprofloxacin injection.The duration of the contract is 1 year from April 2021.
More information
Spend profile
Financial year | Budget |
---|---|
2021/2022 | £0 |
Attachments
-
- 191025 OJEU PIN.pdf
- Tender notice
- OJEU PIN_CM_EMP_15_5473
About the buyer
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
Approach to market date: 8 June 2020